Abstract
To describe the direct costs of patients diagnosed with Axial Spondyloarthritis (axSpA) at the Hospital Militar Central under conventional o DMARD therapy compared with biological therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have